Lv1
10 积分 2026-03-16 加入
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity
5个月前
已完结
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
5个月前
已完结
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
5个月前
已完结
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia
5个月前
已完结
皖公网安备34019202002308
